Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|November 13, 2003
Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumoursD Checkley, J J Tessier, J Kendrew, et al.
Clinical Science (London, England : 1979)|February 1, 1989
Plasma levels of the lyso-derivative of platelet-activating factor are related to ageR R Taylor, M Sturm, P J Kendrew, et al.
Cardiovascular Research|April 1, 1989
Whole blood aggregation, thromboxane release and the lyso derivative of platelet activating factor in myocardial infarction and unstable anginaS M Nidorf, M Sturm, J Strophair, et al.
Journal of Anxiety Disorders|March 23, 2004
The role of anxiety level, coping styles, and cycle phase in menstrual distressSandra T Sigmon, Stacy R Whitcomb-Smith, Kelly J Rohan, et al.
Injury|November 4, 2022
Improving outcomes for amputees: The health-related quality of life and cost utility analysis of osseointegration prosthetics in transfemoral amputeesC Handford, L McMenemy, J Kendrew, et al.
Clinical and Experimental Pharmacology & Physiology|July 1, 1989
Whole blood aggregation and plasma lyso-PAF related to smoking and atherosclerosisM J Sturm, J M Strophair, P J Kendrew, et al.
NMR in Biomedicine|April 27, 2007
Effects of AZD2171 and vandetanib (ZD6474, Zactima) on haemodynamic variables in an SW620 human colon tumour model: an investigation using dynamic contrast-enhanced MRI and the rapid clearance blood pool contrast agent, P792 (gadomelitol)D P Bradley, J L Tessier, D Checkley, et al.
Microcirculation (New York, N.Y. : 1994)|December 17, 2002
ZM323881, a novel inhibitor of vascular endothelial growth factor-receptor-2 tyrosine kinase activityC E Whittles, T M Pocock, S R Wedge, et al.
Archives of Biochemistry and Biophysics|August 10, 2000
Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transportW Abbud, S Habinowski, J Z Zhang, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 2, 2006
Minimal contribution of desmethyl-gefitinib, the major human plasma metabolite of gefitinib, to epidermal growth factor receptor (EGFR)-mediated tumour growth inhibitionD McKillop, S P Guy, M P Spence, et al.
Pageof 3